志苓胶囊联合mFOLFOX6方案用于初治老年晚期直肠癌疗效及其安全性观察(4)
[12]Morimoto M,Miyakura Y,Lefor AT,et al.Reduction in the size of enlarged pelvic lymph nodes after chemoradiation therapy is associated with fewer lymph node metastases in locally advanced rectal carcinoma[J].Surg Today,2015,45(7):834-840.
[13]Stoffregen CC,Odin EA,Carlsson GU,et al.Reduced folate and serum vitamin metabolites in patients with rectal carcinoma:an open-label feasibility study of pemetrexed with folic acid and vitamin B12 supplementation[J].Anticancer Drugs,2016,27(5):439-446.
[14]Wen B,Zhang L,Wang C,et al.Prognostic significance of clinical and pathological stages on locally advanced rectal carcinomaafter neoadjuvant chemoradiotherapy[J].Radiat Oncol,2015,10(1):124.
[15]Julio Garcia-Aguilar,Oliver S Chow,David D Smith,et al.Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer:a multicentre,phase 2 trial[J].Lancet Oncol,2015,16(8):957-966.
[16]Yuji Toiyama,Yasuhiro Inoue,Takahito Kitajima,et al.Conversion Therapy Using mFOLFOX6 With Panitumumab for Unresectable Liver Metastases From Multiple Colorectal Cancers With Familial Adenomatous[J].PolyposisInt Surg,2014,99(6):795-801.
[17]J Randolph Hecht,Edith P Mitchell,Takayuki Yoshino,et al.5-Fluorouracil,leucovorin,and oxaliplatin(mFOLFOX6)plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer:a randomized Phase IIb study[J].Cancer Manag Res,2015(7):165-173.
[18]陳英玉,潘云苓,刘庭波,等.志苓胶囊对人小细胞肺癌细胞系NCI-H446增殖抑制和诱导凋亡的影响[J].中国中西医结合杂志,2007,27(6):531-534.
[19]潘云苓,潘远志.志苓胶囊治疗中晚期肺癌的疗效观察[J].中国中西医结合杂志,2006,26(7):604-607.
[20]郑志宏,潘云苓,陈英玉,等.志苓胶囊通过激活caspase-3抑制K562细胞增殖和诱导细胞凋亡[J].中国药理学通报,2009,25(9):1244-1247., 百拇医药(蔡艳萍 薛顺和)
[13]Stoffregen CC,Odin EA,Carlsson GU,et al.Reduced folate and serum vitamin metabolites in patients with rectal carcinoma:an open-label feasibility study of pemetrexed with folic acid and vitamin B12 supplementation[J].Anticancer Drugs,2016,27(5):439-446.
[14]Wen B,Zhang L,Wang C,et al.Prognostic significance of clinical and pathological stages on locally advanced rectal carcinomaafter neoadjuvant chemoradiotherapy[J].Radiat Oncol,2015,10(1):124.
[15]Julio Garcia-Aguilar,Oliver S Chow,David D Smith,et al.Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer:a multicentre,phase 2 trial[J].Lancet Oncol,2015,16(8):957-966.
[16]Yuji Toiyama,Yasuhiro Inoue,Takahito Kitajima,et al.Conversion Therapy Using mFOLFOX6 With Panitumumab for Unresectable Liver Metastases From Multiple Colorectal Cancers With Familial Adenomatous[J].PolyposisInt Surg,2014,99(6):795-801.
[17]J Randolph Hecht,Edith P Mitchell,Takayuki Yoshino,et al.5-Fluorouracil,leucovorin,and oxaliplatin(mFOLFOX6)plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer:a randomized Phase IIb study[J].Cancer Manag Res,2015(7):165-173.
[18]陳英玉,潘云苓,刘庭波,等.志苓胶囊对人小细胞肺癌细胞系NCI-H446增殖抑制和诱导凋亡的影响[J].中国中西医结合杂志,2007,27(6):531-534.
[19]潘云苓,潘远志.志苓胶囊治疗中晚期肺癌的疗效观察[J].中国中西医结合杂志,2006,26(7):604-607.
[20]郑志宏,潘云苓,陈英玉,等.志苓胶囊通过激活caspase-3抑制K562细胞增殖和诱导细胞凋亡[J].中国药理学通报,2009,25(9):1244-1247., 百拇医药(蔡艳萍 薛顺和)